search
for
 About Bioline  All Journals  Testimonials  Membership  News


Biotecnologia Aplicada
Elfos Scientiae
ISSN: 0684-4551
Vol. 14, No. 4, 1997, pp. 271-274
Bioline Code: ba97062
Full paper language: English
Document type: Research Article
Document available free of charge

Biotecnologia Aplicada, Vol. 14, No. 4, 1997, pp. 271-274

 es
Lopez-Saura, Pedro

Resumen

El papel de los interferones (IFN) en la infeccion por el virus de la inmunodeficiencia humana (VIH) no esta completamente aclarado. Las evidencias de trabajos experimentales y clinicos apuntan en ambas direcciones: como factores patogenicos y como limitantes de la infeccion. Todos los tipos de IFN tienen efecto anti-retroviral in vitro y los ensayos clinicos sugieren que el tratamiento con IFN alfa puede ser beneficioso a individuos seropositivos al VIH en los estadios tempranos de la infeccion. Por el contrario, el VIH puede inducir un IFN acido-labil y su presencia en suero y la de moleculas inducibles por IFN son marcadores de enfermedad avanzada y mal pronostico. El IFN gamma puede facilitar la diseminacion viral pero tambien participa en la defensa contra varios patogenos oportunistas. El resultado global es probablemente un balance entre ambos tipos de acciones, en dependencia de los tipos o subtipos de IFN involucrados en cada etapa de la enfermedad, la presencia de otros patogenos y las relaciones con otras citoquinas.

Palabras-clave
interferon, virus de la inmunodeficiencia humana, sindrome de inmunodeficiencia adquirida

 
 en Is IFN a bad or a good guy in the HIV story?
Lopez-Saura, Pedro

Abstract

The role of interferons (IFN) in human immunodeficiency virus (HIV) infection and disease is not completely clear. Experimental and clinical data point in both directions: as pathogenic and as infection-limiting factors. All types of IFN have anti-retroviral effect in vitro and clinical trials suggest that treatment with IFN alpha can be beneficial to HIV-seropositive individuals at the early stages of infection. Contrarily, HIV induces an acid-labile IFN and its presence in serum as well as IFN- inducible molecules are markers of advanced disease and poor prognosis. IFN gamma can facilitate virus spread but it also participates in the defense against several opportunistic pathogens. The overall result is probably a balance between both kinds of actions. It depends on several factors such as the type or subtype of interferon involved at each stage of disease, other pathogens that can be present, and relations with other cytokines.

Keywords
interferon, human immunodeficiency virus, acquired immune deficiency syndrome

 
© Copyright 1997 Elfos Scientiae
Alternative site location: http://elfosscientiae.cigb.edu.cu/Archivo.asp?Id=6

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil